Illinois Health and Science Corporation acquired IBA Molecular North America, Inc.

Illinois Health and Science Corporation acquired IBA Molecular North America, Inc., a company which develops and markets technologies, pharmaceuticals, and solutions for healthcare with a focus on cancer diagnosis and therapy in Belgium, France, Germany, Italy, Spain, the Netherlands, and the United Kingdom.